跳到主要內容

Ryan Arthur F 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2022/10/5 申報

申報編號
0001883850-22-000076
申報時間
2022/10/5
交易日
2022/10/3
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 14 筆非衍生性交易。公開市場賣出合計 $7.27 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Ryan Arthur FCIK 0001187443董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/10/3Common StockS賣出處分−2$705.39−$1,410.7819,580直接
2022/10/3Common StockS賣出處分−3$710.73−$2,132.1919,577直接
2022/10/3Common StockS賣出處分−5$711.00−$3,55519,572直接
2022/10/3Common StockS賣出處分−2$714.08−$1,428.1619,570直接
2022/10/3Common StockS賣出處分−6$715.94F2−$4,295.6419,564直接
2022/10/3Common StockS賣出處分−2$717.87−$1,435.7419,562直接
2022/10/3Common StockS賣出處分−3$718.48−$2,155.4419,559直接
2022/10/3Common StockS賣出處分−1$726.03−$726.0319,558直接
2022/10/3Common StockS賣出處分−18$727.52F3−$13,095.3619,540直接
2022/10/3Common StockS賣出處分−19$728.23F4−$13,836.3719,521直接
2022/10/3Common StockS賣出處分−2$730.00−$1,46019,519直接
2022/10/3Common StockS賣出處分−6$731.49F5−$4,388.9419,513直接
2022/10/3Common StockS賣出處分−7$732.47F6−$5,127.2919,506直接
2022/10/3Common StockS賣出處分−24$733.64F7−$17,607.3619,482直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 6 shares of Company stock on October 3, 2022 at prices ranging from $715.91 to $715.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 18 shares of Company stock on October 3, 2022 at prices ranging from $727.48 to $727.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 19 shares of Company stock on October 3, 2022 at prices ranging from $728.03 to $728.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 6 shares of Company stock on October 3, 2022 at prices ranging from $731.43 to $731.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 7 shares of Company stock on October 3, 2022 at prices ranging from $732.00 to $732.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 24 shares of Company stock on October 3, 2022 at prices ranging from $733.12 to $733.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 3, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)